ELEV Live signals | Maximize Profits with Getagraph.com

BUY 113709 min ago

@ $2.71

Issued: 14 Feb 2024 @ 10:56

Return: 45.02%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: -6.62 %

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 11:06):

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States...

Stats
Today's Volume	200 747
Average Volume	1.03M
Market Cap	191.20M
EPS	$0 ( 2024-03-14 )
Next earnings date	( $-0.210 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.93
ATR14	$0.0240 (0.61%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-16	Ferra Joseph J Jr	Buy	12 562	Common Stock
2024-03-16	Ferra Joseph J Jr	Sell	4 773	Common Stock
2024-03-16	Ferra Joseph J Jr	Sell	12 562	Restricted Stock Unit
2024-02-29	Sandler Alan B.	Buy	55 000	Stock Option (Right to Buy)
2024-02-29	Cherrington Julie M	Buy	55 000	Stock Option (Right to Buy)

INSIDER POWER
76.11
Last 96 transactions
Buy: 15 904 291 \| Sell: 39 693 676

Volume Correlation

Long: 0.02 (neutral)

Short: 0.87 (strong)

Signal:(40.488) Same movement expected

Elevation Oncology, Inc. Correlation

10 Most Positive Correlations
CRNT	0.959
KROS	0.954
TIOA	0.939
LVO	0.939
PRAX	0.937
DXJS	0.936
LPLA	0.934
COLL	0.933
PPH	0.931
MSDA	0.931

10 Most Negative Correlations
DPRO	-0.938
SRNGW	-0.936
CRCT	-0.934
TBLT	-0.933
RIDE	-0.931
IMBI	-0.927
FFIE	-0.926
MSEX	-0.924
TCFC	-0.923
TENX	-0.922

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Elevation Oncology, Inc. Correlation - Currency/Commodity

0.57
( weak )

0.55
( weak )

0.00
( neutral )

0.46
( neutral )

-0.27
( neutral )

0.55
( weak )

Elevation Oncology, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-39 000.00 (0.00 %)
EPS:	$-1.340

FY	2023
Revenue:	$0
Gross Profit:	$-39 000.00 (0.00 %)
EPS:	$-1.340

FY	2022
Revenue:	$0
Gross Profit:	$-27 000.00 (0.00 %)
EPS:	$-4.09

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.386

Financial Reports:

No articles found.

Elevation Oncology, Inc.

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.